Trials / Recruiting
RecruitingNCT05354947
Ultrasound Effects on Glycemic Control in T2DM
Effects of Multi-Site Abdominal Ultrasound Stimulation on Glycemic Control in T2DM
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Yale University · Academic / Other
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label, exploratory pilot study that will assess the effects of dual site focused pulsed ultrasound treatment on glycemic parameters in subjects with T2DM.
Detailed description
This study will test whether multi-site abdominal ultrasound stimulation can have lasting effects on elevated glucose levels in patients with diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultrasound Delivery | A General Electric LOGIQ E10 ultrasound machine with a C1-6-XD clear probe, will be used to selectively deliver pulsed ultrasound to both, the portal region of the liver and the superior mesenteric plexus. |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2022-05-02
- Last updated
- 2026-01-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05354947. Inclusion in this directory is not an endorsement.